Monash IVF Group Limited (ASX:MVF)
0.7150
-0.0200 (-2.72%)
Oct 17, 2025, 4:10 PM AEST
Monash IVF Group Market Cap
Monash IVF Group has a market cap or net worth of 278.59 million as of October 17, 2025. Its market cap has decreased by -41.87% in one year.
Market Cap
278.59M
Enterprise Value
453.61M
Revenue
271.92M
Ranking
n/a
PE Ratio
11.17
Stock Price
0.72
Market Cap Chart
Since June 26, 2014, Monash IVF Group's market cap has decreased from 534.53M to 278.59M, a decrease of -47.88%. That is a compound annual growth rate of -5.60%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Oct 17, 2025 | 278.59M | -43.70% |
Dec 31, 2024 | 494.84M | -2.31% |
Dec 29, 2023 | 506.53M | 36.13% |
Dec 30, 2022 | 372.10M | -9.48% |
Dec 31, 2021 | 411.06M | 34.39% |
Dec 31, 2020 | 305.86M | 25.33% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
CSL Limited | 105.61B |
Pro Medicus | 29.85B |
Cochlear | 18.68B |
Sonic Healthcare | 10.71B |
Ramsay Health Care | 7.27B |
Telix Pharmaceuticals | 5.63B |
Ansell | 4.82B |
Mesoblast | 3.35B |